尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Dere Willard H, 董事. Director active across 4 companies, notably Biomarin Pharmaceutical INC. Aggregated, 15 reports have been published. History available since 25 May 2021. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
Dere Willard H is Administrateur and has filed 15 forms in total. In the sampled recent filings, the transaction nature is Attribution, with a date range from 2021-05-27 to 2026-06-04, and the main filings concern Biomarin Pharmaceutical INC, Mersana Therapeutics, Inc., Radius Health, Inc. and Seres Therapeutics, Inc.